ScholarLens Back to search
2005•Unpublished venueRequires access

The Study of Quantitative Bedside-testing of Troponin I in Acute Coronary Syndrome

Liang Mei

Open publisher page 0 citations

Abstract

Objective: To evaluate the diagnosis,differentiate diagnosis and prognosis of the quantitative bedside-testing of troponin I(cTnI) in acute coronary syndrome(ACS).Methods: Serum cTnI and CK-MB levels were measured in 60 ACS patients,23 of them were AMI,37of them were UAP,24 of them were none-cadiac chest-pain(control group).Results: Serum cTnI and CK-MB levels in the AMI group were higher than those of UAP group and the control group(P0.0001).cTnI levels in UAP group were higher than those of the control group(P0.001).CK-MB levels haven't striking differences(P0.05),The cTnI positive rate in UAPⅢ were higher than those of UAPⅠand UAPⅡ(P0.001).Conclusion: It is shown that the quatitative bedside-testing of cTnI is a convenient,time-saving method in the differentiate diagnosis and prognosis in ACS.

About this research paper

What this paper is about

Objective: To evaluate the diagnosis,differentiate diagnosis and prognosis of the quantitative bedside-testing of troponin I(cTnI) in acute coronary syndrome(ACS).Methods: Serum cTnI and CK-MB levels were measured in 60 ACS patients,23 of them were AMI,37of them were UAP,24 of them were none-cadiac chest-pain(control group).Results: Serum cTnI and CK-MB levels in the AMI group were higher than those of UAP group and the control group(P0.0001).cTnI levels in UAP group were higher than those of the control group(P0.001).CK-MB levels haven't striking differences(P0.05),The cTnI positive rate in UAPⅢ were higher than those of UAPⅠand UAPⅡ(P0.001).Conclusion: It is shown that the quatitative bedside-testing of cTnI is a convenient,time-saving method in the differentiate diagnosis and prognosis in ACS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the diagnosis,differentiate diagnosis and prognosis of the quantitative bedside-testing of troponin I(cTnI) in acute coronary syndrome(ACS).Methods: Serum cTnI and CK-MB levels were measured in 60 ACS patients,23 of them were AMI,37of them were UAP,24 of them were none-cadiac chest-pain(control group).Results: Serum cTnI and CK-MB levels in the AMI group were higher than those of UAP group and the control group(P0.0001).cTnI levels in UAP group were higher than those of the control group(P0.001).CK-MB levels haven't striking differences(P0.05),The cTnI positive rate in UAPⅢ were higher than those of UAPⅠand UAPⅡ(P0.001).Conclusion: It is shown that the quatitative bedside-testing of cTnI is a convenient,time-saving method in the differentiate diagnosis and prognosis in ACS.

Key concepts: Troponin I, Medicine, Acute coronary syndrome, Internal medicine, Cardiology, Chest pain, Troponin, Myocardial infarction

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The Study of Quantitative Bedside-testing of Troponin I in Acute Coronary Syndrome — Research Paper | ScholarLens